Penwest MCC E5B8L80X Brooklyn - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

Penwest MCC E5B8L80X Brooklyn

Description:

COMPRESS. BOTTLE. PACKAGING. LEVEL 2: REPEATABLE. WEIGHING. GRANULATION. FB DRY. MILLING ... COMPRESS. BOTTLE. PACKAGING. LEVEL 3: DEFINED. Minimum. Requirement ' ... – PowerPoint PPT presentation

Number of Views:235
Avg rating:3.0/5.0
Slides: 31
Provided by: tony89
Learn more at: http://www.fda.gov
Category:

less

Transcript and Presenter's Notes

Title: Penwest MCC E5B8L80X Brooklyn


1
QUALITY BY DESIGN The Means To Fundamental
Manufacturing Science
G.K.Raju, Ph.D.
Sept 17th 2003
2
OUTLINE
  • MOTIVATION
  • MANUFACTURING SCIENCE DIMENSIONS
  • QUALITY BY DESIGN THE LEVERAGES
  • QUALITY BY DESIGN THE COMPONENTS
  • CONSIDERATIONS

3
MANUFACTURING SYSTEM
  • A manufacturing system is set of processes and
    systems (and people) bound by a common material
    and information flow.

Information
Information
Material
Material
4
PHARMACEUTICAL MANUFACTURING SYSTEM
SPACE
RESEARCH
QUALITY
ACTIVE
FORMULN
FILL
PACK
DEVELOPMENT
TIME
ACTIVE
FORMULN
FILL
PACK
COST
MANUFACTURING
ACTIVE
FORMULN
FILL
PACK
SAFETY
TIME
5
PROCESS A WITH QC TESTS
BLEND
STEP
FB DRY
DRY MIX
WEIGHING
WET GRANULATION
STEP
ENCAPSULATE
SIEVE
QC1
QC3
QC4
QC2
  • Particle Size
  • LOD
  • API
  • MICRO
  • Description
  • ID
  • Assay
  • CU
  • Impurity
  • Dissolution
  • MICRO

6
QUALITY TESTING END OF LINECONSUMES
SIGNIFICANT TIME
Overall Cycle Time Components
25
20
15
TIME
(Days)
Process Times
10
QC Testing Times
5
0
A
B
C
D
E
F
7
QUALITY TESTING END OF LINE MAKES IT DIFFICULT
TO UNDERSTAND EXCEPTIONS
Lots with Exceptions
Lots without Exceptions
OVERALL CYCLE TIMES
0
100
200
300
400
500
600
700
800
LOT NUMBER
8
PHARMA MANUFACTURING CYCLE TIMES (DAYS)HALF A
YEAR, LITTLE IMPROVEMENT.
Derived from COGS numbers
9
OUTLINE
  • MOTIVATION
  • MANUFACTURING SCIENCE DIMENSIONS
  • QUALITY BY DESIGN THE LEVERAGES
  • QUALITY BY DESIGN THE COMPONENTS
  • CONSIDERATIONS

10
MANUFACTURING SCIENCEDIMENSIONS
  • Body of
  • Knowledge, Laws, Principles
  • Involved In The Transformation of
  • Materials and Information into Goods
  • for the Satisfaction of Human Needs

Extent Of Mfg. Science
11
MANUFACTURING SCIENCE Levels of Knowledge
LEVEL 5
First Principles
Extent Of Mfg. Science Or Quality By Design
MECHANISTIC KNOWLEDGE
LEVEL 4
LEVEL 3
CAUSAL KNOWLEDGE Why?
PROCESS KNOWLEDGE How, Correlative ..
LEVEL 2
DESCRIPTIVE KNOWLEDGE What, Etc,
LEVEL 1
12
MANUFACTURING SCIENCEThe Time DimensionTHE
DESIRED STATE
Right First Time
LEVEL 5
Manufacturing Centric Approach to Manufacturing
Science (learning by doing)
Design/Development Centric Approach Manufacturing
Science (learning before doing)
LEVEL 4
Extent Of Mfg. Science
LEVEL 3
LEVEL 2
FDA Minimum Requirement
LEVEL 1
Time
13
EXTENT OF MANUFACTURING SCIENCECOST, QUALITY
AND TIME OPPORTUNITY
Right First Time
Desired
LEVEL 5
Cost Quality Time Opportunity
Design/Development Centric Approach Manufacturing
Science (learning before doing)
LEVEL 4
Manufacturing Centric Approach to Manufacturing
Science (learning by doing)
Extent Of Mfg. Science
LEVEL 3
Actual
LEVEL 2
FDA Minimum Requirement
LEVEL 1
Time
14
OUTLINE
  • MOTIVATION
  • MANUFACTURING SCIENCE DIMENSIONS
  • QUALITY BY DESIGN THE LEVERAGES
  • QUALITY BY DESIGN THE COMPONENTS
  • CONSIDERATIONS

15
QUALITY BY DESIGNTHE LEVERAGES
Right First Time
LEVEL 5
Extent Of Mfg. Science Or Quality By Design
Manufacturing Centric Approach to Manufacturing
Science (learning by doing)
LEVEL 4
Strategic Leverage
Tactical Leverage
LEVEL 3
Design/Development Centric Approach Manufacturing
Science (learning before doing)
LEVEL 2
FDA Minimum Requirement
LEVEL 1
Time
16
QUALITY BY DESIGNSTRATEGIC LEVERAGE Learning
Before Doing
  • Significantly Enhanced Level of Product Process
    Understanding BEFORE Commercial Manufacturing
  • Enables Mechanistic Basis for Setting Product and
    Process Quality Specifications
  • Impact Over Whole Lifecycle
  • Easier to Make Fundamental Process Design Changes
    (Fewer Regulatory Barriers)

17
QUALITY BY DESIGNSTRATEGIC LEVERAGE Learning
By Doing
  • Enhanced Level of Product Process
    Understanding DURING Commercial Manufacturing
  • Potential To Leverage Large Amounts of Production
    Data
  • Investigation/Exceptions Provide Opportunity To
    Learn
  • Difficult to Make Significant Product Process
    Changes
  • Rarely an environment to develop mechanistic
    understanding

18
QUALITY BY DESIGN A PROCESS ROADMAP
LEVEL 5 OPTIMIZING
FILM COATING
BOTTLE PACKAGING
COMPRESS
WEIGHING
BLEND
LEVEL 4 MANAGED
LEVEL 3 DEFINED
FILM COATING
BOTTLE PACKAGING
GRANULATION
MILLING
COMPRESS
WEIGHING
FB DRY
BLEND
LEVEL 2 REPEATABLE
LEVEL 1 INITIAL
19
OUTLINE
  • MOTIVATION
  • MANUFACTURING SCIENCE DIMENSIONS
  • QUALITY BY DESIGN THE LEVERAGES
  • QUALITY BY DESIGN THE COMPONENTS
  • CONSIDERATIONS

20
QUALITY BY DESIGNCOMPONENTS
Extent Of Manufacturing Science Or Quality By
Design
PROCESS PRODUCT
Y F(X)
21
COMPONENTS OF QUALITY BY DESIGNA-PRIORI
KNOWLEDGE
  • How Much Was Known About This Product Process
    Before?
  • API
  • Excipients
  • Etc.
  • What Kind of A-Priori Knowledge Exists?
  • First Principle Knowledge
  • Mechanistic Knowledge
  • Causal Knowledge
  • Correlative Knowledge
  • Descriptive Knowledge

22
COMPONENTS OF QUALITY BY DESIGNINFORMATION
EXCHANGE EXTENT AND TYPE
WHAT IS THE QUALITY AND QUANTITY OF DATA USED
23
ON-LINE TECHNOLOGY IMPACTSDOMINANT CYCLE TIMES
On-line LIF, NIR, Pattern Recognition, etc.
24
MANUFACTURING SYSTEM ROADMAP CURRENT Relative
To DESIRED State
LEVEL 5 OPTIMIZING
FILM COATING
BOTTLE PACKAGING
COMPRESS
WEIGHING
BLEND
LEVEL 4 MANAGED
LEVEL 3 DEFINED
FILM COATING
BOTTLE PACKAGING
GRANULATION
MILLING
COMPRESS
WEIGHING
FB DRY
BLEND
CURRENT STATE
LEVEL 2 REPEATABLE
Minimum Requirement
LEVEL 1 INITIAL
25
COMPONENTS OF QUALITY BY DESIGNPERFORMANCE
MEASUREMENT
  • Safety and Efficacy
  • Process Capability Associated With
    Critical-To-Quality (CTQ) Variables
  • Variability of Critical-To-Quality Variables
  • Predictive Ability Of Performance

26
MANUFACTURING SCIENCE DESIRED RELATIVE TO
CURRENT STATE(Personal Opinion)
Right First Time
LEVEL 5
Design/Development Centric Approach Manufacturing
Science (learning before doing)
Manufacturing Centric Approach to Manufacturing
Science (learning by doing)
LEVEL 4
Extent Of Mfg. Science
LEVEL 3
LEVEL 2
FDA Minimum Requirement
LEVEL 1
Time
27
OUTLINE
  • MOTIVATION
  • MANUFACTURING SCIENCE DIMENSIONS
  • QUALITY BY DESIGN THE LEVERAGES
  • QUALITY BY DESIGN THE COMPONENTS
  • CONSIDERATIONS

28
QUALITY BY DESIGNIS THE EXTENT OF RIGHT FIRST
TIME
CONSENT DECREE
WARNING LETTER
Time ( cost) Associated With Addressing
Cause For Not Being Right
External Failure
Common Focus
FDA 483
RECALLS
COMPLAINTS
Internal Failure
REJECTS
QA APPROVAL
Appraisal
FINAL QC TESTING
IN-PROCESS TESTING
DEVELOPMENT
Prevention
Where Right is Measured
29
MANUFACTURING SCIENCE IMPLICATIONS
LEVEL 5
LEVEL 5
First Principles
  • Lower Risk
  • Higher
  • Process
  • Understanding
  • Lower
  • Variability
  • Lower
  • Costs

Extent Of Mfg. Science Or Quality By Design
LEVEL 4
MECHANISTIC KNOWLEDGE
LEVEL 3
CAUSAL KNOWLEDGE Why?
PROCESS KNOWLEDGE How, Correlative ..
LEVEL 2
DESCRIPTIVE KNOWLEDGE What, Etc,
LEVEL 1
30
MANUFACTURING SCIENCE IMPLICATIONS
LEVEL 5
First Principles
LEVEL 4
Extent Of Mfg. Science Or Quality By Design
MECHANISTIC KNOWLEDGE
LEVEL 3
CAUSAL KNOWLEDGE Why?
FDA
PROCESS KNOWLEDGE How, Correlative ..
LEVEL 2
DESCRIPTIVE KNOWLEDGE What, Etc,
LEVEL 1
Write a Comment
User Comments (0)
About PowerShow.com